These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16364997)

  • 21. Pregnancy weight gain and premenopausal breast cancer risk.
    Hilakivi-Clarke L; Luoto R; Huttunen T; Koskenvuo M
    J Reprod Med; 2005 Nov; 50(11):811-6. PubMed ID: 16419626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The lipidome as a composite biomarker of the modifiable part of the risk of breast cancer.
    Bougnoux P; Hajjaji N; Couet C
    Prostaglandins Leukot Essent Fatty Acids; 2008; 79(3-5):93-6. PubMed ID: 18930643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Folate and risk of breast cancer: a meta-analysis.
    Larsson SC; Giovannucci E; Wolk A
    J Natl Cancer Inst; 2007 Jan; 99(1):64-76. PubMed ID: 17202114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiparity and the risk of premenopausal breast cancer: different effects across ethnic groups in Singapore.
    Verkooijen HM; Yap KP; Bhalla V; Chow KY; Chia KS
    Breast Cancer Res Treat; 2009 Feb; 113(3):553-8. PubMed ID: 18311581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role and impact of menstrual and reproductive factors on breast cancer risk in Japan.
    Iwasaki M; Otani T; Inoue M; Sasazuki S; Tsugane S;
    Eur J Cancer Prev; 2007 Apr; 16(2):116-23. PubMed ID: 17297387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opportunities and strategies for breast cancer prevention through risk reduction.
    Mahoney MC; Bevers T; Linos E; Willett WC
    CA Cancer J Clin; 2008; 58(6):347-71. PubMed ID: 18981297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anthropometry and breast cancer risk in Nigerian women.
    Okobia MN; Bunker CH; Zmuda JM; Osime U; Ezeome ER; Anyanwu SN; Uche EE; Ojukwu J; Kuller LH
    Breast J; 2006; 12(5):462-6. PubMed ID: 16958966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
    J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case-control study of lifestyle and lung cancer associations by histological types.
    Kubik A; Zatloukal P; Tomasek L; Dolezal J; Syllabova L; Kara J; Kopecky P; Plesko I
    Neoplasma; 2008; 55(3):192-9. PubMed ID: 18348651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for breast cancer in Turkish women: a hospital-based case-control study.
    Beji NK; Reis N
    Eur J Cancer Care (Engl); 2007 Mar; 16(2):178-84. PubMed ID: 17371428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic effect of paclitaxel and propolis on lipid peroxidation and antioxidant system in 7,12 dimethyl benz(a)anthracene-induced breast cancer in female Sprague Dawley rats.
    Padmavathi R; Senthilnathan P; Chodon D; Sakthisekaran D
    Life Sci; 2006 May; 78(24):2820-5. PubMed ID: 16375927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast cancer risk factors and second primary malignancies among women with breast cancer.
    Trentham-Dietz A; Newcomb PA; Nichols HB; Hampton JM
    Breast Cancer Res Treat; 2007 Oct; 105(2):195-207. PubMed ID: 17186360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Augmented antioxidant status in Tamoxifen treated postmenopausal women with breast cancer on co-administration with Coenzyme Q10, Niacin and Riboflavin.
    Yuvaraj S; Premkumar VG; Vijayasarathy K; Gangadaran SG; Sachdanandam P
    Cancer Chemother Pharmacol; 2008 May; 61(6):933-41. PubMed ID: 17668211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormones and progeny of breast tumor cells.
    Schneider HP; Böcker W
    Climacteric; 2006 Apr; 9(2):88-107. PubMed ID: 16698656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.
    Giordano G; Gnetti L; Merisio C; Melpignano M
    Maturitas; 2007 Feb; 56(2):190-7. PubMed ID: 16963204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obesity and prognosis of breast cancer.
    Carmichael AR
    Obes Rev; 2006 Nov; 7(4):333-40. PubMed ID: 17038127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertension, diuretics and breast cancer risk.
    Largent JA; McEligot AJ; Ziogas A; Reid C; Hess J; Leighton N; Peel D; Anton-Culver H
    J Hum Hypertens; 2006 Oct; 20(10):727-32. PubMed ID: 16885996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of lifestyle factors on gynaecological cancer.
    Rieck G; Fiander A
    Best Pract Res Clin Obstet Gynaecol; 2006 Apr; 20(2):227-51. PubMed ID: 16543119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physical activity and postmenopausal breast cancer: proposed biologic mechanisms and areas for future research.
    Neilson HK; Friedenreich CM; Brockton NT; Millikan RC
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):11-27. PubMed ID: 19124476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.